The Chinese State Food and Drug Administration has banned the import, sale and use of the Indian pharmaceutical firm, Dr Reddy’s, amoxetine hydrochloride capsules.

Atomoxetine hydrochloride is a selective norepinephrine reuptake inhibitor used to treat Attention-Deficit Hyperactivity Disorder (ADHD).